Literature DB >> 19968233

Unusual radiographic appearance of adamantinoma.

Michele Cappuccio1, Maurizio Montalti, Giuseppe Bosco, Alessandro Gasbarrini, Stefano Boriani.   

Abstract

Adamantinoma is a rare tumor with an indolent course that occurs most commonly in the tibia. It is locally aggressive, and local recurrences are described after resection. Pain is the most common symptom. Since the lesion is typically slow growing, the pain can be present for many years before the patient seeks medical attention. Microscopically, adamantinoma consists of islands of epithelial cells in a fibrous stroma. Nuclear atypia is minimal, and mitotic figures are rare. The most common radiographic appearance is that of multiple sharply demarcated radiolucent lesions surrounded by areas of dense, sclerotic bone. This tumor most often affects the tibial diaphysis and produces lytic lesions that can cause fractures. A 31-year-old man presented with a rapidly growing lytic lesion of the distal tibia. On histological examination, many areas of epithelial cells in a fibrous stroma were identified. Diagnosis of adamantinoma was performed. The lesion was treated with en bloc resection and reconstruction with distal tibia allograft and ankle arthrodesis with retrograde nail. At 2-year follow-up, there were no clinical or radiological signs of recurrence of disease. Copyright 2009, SLACK Incorporated.

Entities:  

Mesh:

Year:  2009        PMID: 19968233     DOI: 10.3928/01477447-20091020-22

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  2 in total

1.  Multifocal adamantinoma simulating traumatic pathology on bone scanning.

Authors:  Muhammad Babar Imran; Muhammad Naeem
Journal:  Rheumatol Int       Date:  2010-07-28       Impact factor: 2.631

Review 2.  Clinical applications of allografts in foot and ankle surgery.

Authors:  Pedro Diniz; Jácome Pacheco; Miguel Flora; Diego Quintero; Sjoerd Stufkens; Gino Kerkhoffs; Jorge Batista; Jon Karlsson; Hélder Pereira
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-02-05       Impact factor: 4.342

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.